CGTX / Cognition Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Cognition Therapeutics, Inc.
US ˙ NasdaqCM ˙ US19243B1026

Deler fremragende 89,353,773 shares
Insideraktier13.184.962 shares
Insider ejerskab14,76 %
Total Insiders16
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

3 ( )
80 out of 10989

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.035% ( )
348 out of 10855

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Cognition Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
BIOS Fund III NT, LP 10% Owner - [10%] 1.424.014 6.048.500
BIOS Memory SPV I, LP 10% Owner - [10%] 1.424.014 6.048.500
Bios Clinical Opportunity Fund, LP Director, 10% Owner - [D] [10%] 1.000.190 1.000.190
Breedlove Mark H. Director - [D] 404.439 404.439
Anthony Caggiano Chief Medical Officer - [O] 874.906 874.906
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
John Brendan Doyle Chief Financial Officer - [O] 627.509 627.509
Fletcher Aaron G.L. Director, 10% Owner - [D] [10%] 56.229 56.229
Golden Seeds Cognition Therapeutics LLC 10% Owner - [10%] 0 0
Khattar Jack A. Director - [D] 48.500 48.500
Kreis Leslie W. 10% Owner - [10%] 6.048.500 6.048.500
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Brett P Monia Director - [D] 48.500 48.500
James Michael O'Brien Chief Financial Officer - [O] 5.000 5.000
Ogden CAP Associates, LLC 10% Owner - [10%] 2.210.377 2.210.377
Ellen B Richstone Director - [D] 58.500 58.500
Lisa Ricciardi CEO & President, Director - [D] [O] 1.715.851 1.715.851
Peggy Wallace Director - [D] 86.461 86.461

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CGTX / Cognition Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2026-04-16 Ricciardi Lisa 9.175 1,1000 9.175 1,1000 10.092 6 1.2900 1.744 17,28
2026-04-16 Caggiano Anthony 10.000 1,1100 10.000 1,1100 11.100
2026-04-16 Doyle John Brendan 10.000 1,1300 10.000 1,1300 11.300
2025-01-31 Ricciardi Lisa 38.851 0,7722 38.851 0,7722 30.001
2024-03-14 Ricciardi Lisa 5.700 1,7500 5.700 1,7500 9.975
2022-11-29 RICHSTONE ELLEN B 10.000 2,6550 10.000 2,6550 26.550
2022-11-28 Kreis Leslie W. 1.973 2,6497 1.973 2,6497 5.228
2022-11-28 Kreis Leslie W. 12.220 2,6497 12.220 2,6497 32.379
2022-11-28 Kreis Leslie W. 1.871 2,6497 1.871 2,6497 4.958

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CGTX / Cognition Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CGTX / Cognition Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-10-13 Breedlove Mark H. 12 12,0000 12 12,0000 141 252 1.5000 -124 -88,21
2021-10-13 Fletcher Aaron G.L. 90 12,0000 90 12,0000 1.083
2021-10-13 Golden Seeds Cognition Therapeutics LLC 33 12,0000 33 12,0000 397
2021-10-13 Ogden CAP Associates, LLC 74 12,0000 74 12,0000 889
2021-10-13 BIOS Memory SPV I, LP 90 12,0000 90 12,0000 1.083

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CGTX / Cognition Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-20 2026-04-16 4 Doyle John Brendan CGTX Common Stock P - Purchase D 1,1300 10.000 11 627.509
2026-04-20 2026-04-16 4 Ricciardi Lisa CGTX Common Stock P - Purchase D 1,1000 9.175 10 1.715.851
2026-04-20 2026-04-16 4 Caggiano Anthony CGTX Common Stock P - Purchase D 1,1100 10.000 11 874.906
2026-02-18 2026-02-15 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 1,1200 -5.850 -7 1.706.676
2026-02-18 2026-02-15 4 Doyle John Brendan CGTX Common Stock F - Taxes D 1,1200 -1.560 -2 617.509
2026-02-18 2026-02-15 4 Caggiano Anthony CGTX Common Stock F - Taxes D 1,1200 -4.680 -5 864.906
2026-02-05 2026-02-04 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 1,0300 -51.704 -53 1.712.526
2026-02-05 2026-02-03 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 1,1200 -26.036 -29 1.764.230
2026-02-05 2026-02-03 4 Ricciardi Lisa CGTX Common Stock A - Award D 800.000 1.790.266
2026-02-05 2026-02-04 4 Doyle John Brendan CGTX Common Stock F - Taxes D 1,0300 -26.921 -28 619.069
2026-02-05 2026-02-03 4 Doyle John Brendan CGTX Common Stock A - Award D 200.000 645.990
2026-02-05 2026-02-04 4 Caggiano Anthony CGTX Common Stock F - Taxes D 1,0300 -26.919 -28 869.586
2026-02-05 2026-02-03 4 Caggiano Anthony CGTX Common Stock F - Taxes D 1,1200 -11.488 -13 896.505
2026-02-05 2026-02-03 4 Caggiano Anthony CGTX Common Stock A - Award D 400.000 907.993
2025-12-22 2025-12-18 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 1,5000 -23.400 -35 990.266
2025-12-22 2025-12-18 4 Ricciardi Lisa CGTX Common Stock A - Award D 75.000 1.013.666
2025-12-22 2025-12-18 4 Doyle John Brendan CGTX Common Stock F - Taxes D 1,5000 -9.360 -14 445.990
2025-12-22 2025-12-18 4 Doyle John Brendan CGTX Common Stock A - Award D 30.000 455.350
2025-12-22 2025-12-18 4 Caggiano Anthony CGTX Common Stock F - Taxes D 1,5000 -20.280 -30 507.993
2025-12-22 2025-12-18 4 Caggiano Anthony CGTX Common Stock A - Award D 65.000 528.273
2025-09-23 2025-09-19 4 Fletcher Aaron G.L. CGTX Common Stock M - Exercise D 0,8400 7.729 6 56.229
2025-07-31 2025-07-29 4 Doyle John Brendan CGTX Common Stock F - Taxes D 0,6702 -9.360 -6 425.350
2025-07-31 2025-07-29 4 Doyle John Brendan CGTX Common Stock A - Award D 30.000 434.710
2025-07-31 2025-07-29 4 Caggiano Anthony CGTX Common Stock F - Taxes D 0,6702 -20.281 -14 463.273
2025-07-31 2025-07-29 4 Caggiano Anthony CGTX Common Stock A - Award D 65.000 483.554
2025-07-31 2025-07-29 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 0,6702 -23.400 -16 938.666
2025-07-31 2025-07-29 4 Ricciardi Lisa CGTX Common Stock A - Award D 75.000 962.066
2025-06-23 2025-06-18 4 Khattar Jack A. CGTX Common Stock A - Award D 34.000 48.500
2025-06-23 2025-06-18 4 Monia Brett P CGTX Common Stock A - Award D 34.000 48.500
2025-06-23 2025-06-18 4 RICHSTONE ELLEN B CGTX Common Stock A - Award D 34.000 58.500
2025-06-23 2025-06-18 4 Wallace Peggy CGTX Common Stock A - Award D 34.000 86.461
2025-06-20 2025-06-18 4 Kreis Leslie W. CGTX Common Stock A - Award I 34.000 48.500
2025-06-20 2025-06-18 4 Fletcher Aaron G.L. CGTX Common Stock A - Award D 34.000 48.500
2025-05-02 2025-05-01 4 Doyle John Brendan CGTX Common Stock F - Taxes D 0,4472 -9.692 -4 404.710
2025-02-18 2025-02-15 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 0,5901 -6.619 -4 887.066
2025-02-18 2025-02-15 4 Doyle John Brendan CGTX Common Stock F - Taxes D 0,5901 -1.723 -1 414.402
2025-02-18 2025-02-15 4 Caggiano Anthony CGTX Common Stock F - Taxes D 0,5901 -5.296 -3 418.554
2025-02-04 2025-02-04 4 Doyle John Brendan CGTX Common Stock A - Award D 295.000 416.125
2025-02-04 2025-02-04 4 Caggiano Anthony CGTX Common Stock A - Award D 295.000 423.850
2025-02-04 2025-02-03 4 Caggiano Anthony CGTX Common Stock F - Taxes D 0,6660 -12.779 -9 128.850
2025-02-04 2025-02-04 4 Ricciardi Lisa CGTX Common Stock A - Award D 631.300 893.685
2025-02-04 2025-02-03 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 0,6660 -28.960 -19 262.385
2025-02-04 2025-01-31 4 Ricciardi Lisa By Spouse CGTX Common Stock P - Purchase I 0,7722 38.851 30 38.851
2024-06-11 2024-06-07 4 Fletcher Aaron G.L. CGTX Common Stock A - Award D 8.500 14.500
2024-06-11 2024-06-07 4 Kreis Leslie W. CGTX Common Stock A - Award I 8.500 14.500
2024-06-11 2024-06-07 4 Wallace Peggy CGTX Common Stock A - Award D 8.500 52.461
2024-06-11 2024-06-07 4 RICHSTONE ELLEN B CGTX Common Stock A - Award D 8.500 24.500
2024-06-11 2024-06-07 4 Khattar Jack A. CGTX Common Stock A - Award D 8.500 14.500
2024-06-11 2024-06-07 4 Monia Brett P CGTX Common Stock A - Award D 8.500 14.500
2024-05-03 2024-05-01 4 Doyle John Brendan CGTX Common Stock F - Taxes D 1,9500 -8.699 -17 121.125
2024-03-14 2024-03-14 4 Ricciardi Lisa CGTX Common Stock P - Purchase D 1,7500 5.700 10 291.345
2024-02-20 2024-02-15 4 Caggiano Anthony CGTX Common Stock A - Award D 60.000 141.629
2024-02-20 2024-02-15 4 Doyle John Brendan CGTX Common Stock A - Award D 20.000 129.824
2024-02-20 2024-02-15 4 Ricciardi Lisa CGTX Common Stock A - Award D 75.000 285.645
2024-02-09 2024-02-03 4 Caggiano Anthony CGTX Common Stock F - Taxes D 2,2900 -12.777 -29 81.629
2024-02-09 2024-02-03 4 Ricciardi Lisa CGTX Common Stock F - Taxes D 2,2900 -27.828 -64 210.645
2023-11-13 3 Bios Clinical Opportunity Fund, LP CGTX Common Stock D 500.095
2023-11-13 2023-11-08 4 Fletcher Aaron G.L. By Bios Clinical Opportunity Fund, LP CGTX Common Stock A - Award I 1,0500 500.095 525 500.095
2023-11-13 2023-11-08 4 Kreis Leslie W. By Bios Clinical Opportunity Fund, LP CGTX Common Stock A - Award I 1,0500 500.095 525 500.095
2023-06-13 2023-06-09 4 Kreis Leslie W. CGTX Common Stock A - Award I 6.000 6.000
2023-06-13 2023-06-09 4 Fletcher Aaron G.L. CGTX Common Stock A - Award D 6.000 6.000
2023-06-13 2023-06-09 4 Wallace Peggy CGTX Common Stock A - Award D 6.000 43.961
2023-06-13 2023-06-09 4 Monia Brett P CGTX Common Stock A - Award D 6.000 6.000
2023-06-13 2023-06-09 4 Khattar Jack A. CGTX Common Stock A - Award D 6.000 6.000
2023-06-13 2023-06-09 4 RICHSTONE ELLEN B CGTX Common Stock A - Award D 6.000 16.000
2023-05-03 2023-05-01 4 Doyle John Brendan CGTX Common Stock A - Award D 109.824 109.824
2023-02-07 2023-02-03 4 Ricciardi Lisa CGTX Common Stock A - Award D 213.973 238.473
2023-02-07 2023-02-03 4 Caggiano Anthony CGTX Common Stock A - Award D 94.406 94.406
2022-11-29 2022-11-29 4 RICHSTONE ELLEN B CGTX Common Stock P - Purchase D 2,6550 10.000 27 10.000
2022-11-29 2022-11-28 4 Fletcher Aaron G.L. By Bios Fund III, LP CGTX Common Stock P - Purchase I 2,6497 1.871 5 309.748
2022-11-29 2022-11-28 4 Fletcher Aaron G.L. By Bios Fund III QP, LP CGTX Common Stock P - Purchase I 2,6497 12.220 32 2.021.906
2022-11-29 2022-11-28 4 Fletcher Aaron G.L. By Bios Fund III NT, LP CGTX Common Stock P - Purchase I 2,6497 1.973 5 326.733
2022-11-29 2022-11-28 4 Kreis Leslie W. By Bios Fund III, LP CGTX Common Stock P - Purchase I 2,6497 1.871 5 309.748
2022-11-29 2022-11-28 4 Kreis Leslie W. By Bios Fund III QP, LP CGTX Common Stock P - Purchase I 2,6497 12.220 32 2.021.906
2022-11-29 2022-11-28 4 Kreis Leslie W. By Bios Fund III NT, LP CGTX Common Stock P - Purchase I 2,6497 1.973 5 326.733
2022-11-17 2022-11-16 4 Fletcher Aaron G.L. Bios Fund III, LP CGTX Common Stock P - Purchase I 1,4000 8.269 12 307.877
2022-11-17 2022-11-16 4 Fletcher Aaron G.L. By Bios Fund III QP, LP CGTX Common Stock P - Purchase I 1,4000 54.009 76 2.009.686
2022-11-17 2022-11-16 4 Fletcher Aaron G.L. By Bios Fund III NT, LP CGTX Common Stock P - Purchase I 1,4000 8.722 12 324.760
2022-11-17 2022-11-16 4 Kreis Leslie W. Bios Fund III, LP CGTX Common Stock P - Purchase I 1,4000 8.269 12 307.877
2022-11-17 2022-11-16 4 Kreis Leslie W. By Bios Fund III QP, LP CGTX Common Stock P - Purchase I 1,4000 54.009 76 2.009.686
2022-11-17 2022-11-16 4 Kreis Leslie W. By Bios Fund III NT, LP CGTX Common Stock P - Purchase I 1,4000 8.722 12 324.760
2022-11-16 2022-11-15 4 Wallace Peggy CGTX Common Stock P - Purchase D 1,2000 12.500 15 37.961
2022-11-16 2022-11-15 4 Ricciardi Lisa CGTX Common Stock P - Purchase D 1,3000 12.000 16 24.500
2022-11-16 2022-11-15 4 Fletcher Aaron G.L. Bios Fund III, LP CGTX Common Stock P - Purchase I 1,2000 174.700 210 299.608
2022-11-16 2022-11-15 4 Fletcher Aaron G.L. By Bios Fund III QP, LP CGTX Common Stock P - Purchase I 1,2000 1.141.030 1.369 1.955.677
2022-11-16 2022-11-15 4 Fletcher Aaron G.L. By Bios Fund III NT, LP CGTX Common Stock P - Purchase I 1,2000 184.270 221 316.038
2022-11-16 2022-11-15 4 Kreis Leslie W. Bios Fund III, LP CGTX Common Stock P - Purchase I 1,2000 174.700 210 299.608
2022-11-16 2022-11-15 4 Kreis Leslie W. By Bios Fund III QP, LP CGTX Common Stock P - Purchase I 1,2000 1.141.030 1.369 1.955.677
2022-11-16 2022-11-15 4 Kreis Leslie W. By Bios Fund III NT, LP CGTX Common Stock P - Purchase I 1,2000 184.270 221 316.038
2022-09-29 2022-09-27 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock J - Other D -2.489.682 0
2022-09-29 2022-09-27 4 Wallace Peggy CGTX Common Stock J - Other D 22.461 25.461
2022-03-25 2022-03-23 4 O'Brien James Michael CGTX Stock Option (right to buy) A - Award D 3,05 50.000 50.000
2022-03-25 2022-03-23 4 Caggiano Anthony CGTX Stock Option (right to buy) A - Award D 3,05 25.000 25.000
2022-02-01 2022-01-31 4 Fletcher Aaron G.L. By BP Directors, LP CGTX Stock Option (right to buy) J - Other I 1,75 1.145 1.145
2022-02-01 2022-01-31 4 Fletcher Aaron G.L. CGTX Stock Option (right to buy) J - Other D 1,75 -1.145 2.719
2022-02-01 2021-10-13 4/A BIOS Memory SPV I, LP CGTX Common Stock C - Conversion D 1.424.014 1.424.014
2022-02-01 2021-10-13 4/A Fletcher Aaron G.L. By Bios Memory SPV I, LP CGTX Common Stock C - Conversion I 1.424.014 1.424.014
2021-11-10 2021-11-01 4 Caggiano Anthony CGTX Stock Option (right to buy) A - Award D 12,10 161.676 161.676
2021-11-03 2021-11-01 4 RICHSTONE ELLEN B CGTX Stock Option (right to buy) A - Award D 12,10 16.670 16.670
2021-10-25 2021-10-13 4 Wallace Peggy CGTX Common Stock P - Purchase D 12,0000 3.000 36 3.000
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, NT, LP. CGTX Simple Agreement for Future Equity C - Conversion I -25.593 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, QP, LP. CGTX Simple Agreement for Future Equity C - Conversion I -158.476 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, LP. CGTX Simple Agreement for Future Equity C - Conversion I -24.263 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Memory SPV II, LP. CGTX Warrant (right to buy) X - Other I 0,03 -33.495 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, NT, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -111.504 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, QP, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -1.930.673 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -134.626 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, NT, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -110.744 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Memory SPV II, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -1.138.040 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, QP, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -827.275 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -253.256 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund I, QP, LP. CGTX Series B Convertible Preferred Stock C - Conversion I -792.547 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund I, LP. CGTX Series B Convertible Preferred Stock C - Conversion I -1.355.017 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP CGTX Series B Convertible Preferred Stock C - Conversion D -4.605.985 0
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, NT, LP. CGTX Common Stock C - Conversion I 25.593 60.065
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, NT, LP. CGTX Common Stock C - Conversion I 34.472 34.472
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, QP, LP. CGTX Common Stock P - Purchase I 12,0000 144.530 1.734 899.905
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, QP, LP. CGTX Common Stock C - Conversion I 158.476 755.375
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, QP, LP. CGTX Common Stock C - Conversion I 596.899 596.899
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, LP. CGTX Common Stock P - Purchase I 12,0000 22.129 266 88.012
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, LP. CGTX Common Stock C - Conversion I 24.263 65.883
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund III, LP. CGTX Common Stock C - Conversion I 41.620 41.620
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Memory SPV II, LP. CGTX Common Stock S - Sale I 12,0000 -90 -1 385.248
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Memory SPV II, LP. CGTX Common Stock X - Other I 0,0320 33.495 1 385.339
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Memory SPV II, LP. CGTX Common Stock C - Conversion I 351.844 351.844
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, NT, LP. CGTX Common Stock P - Purchase I 12,0000 23.341 280 57.579
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, NT, LP. CGTX Common Stock C - Conversion I 34.238 34.238
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, QP, LP. CGTX Common Stock C - Conversion I 255.765 255.765
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund II, LP. CGTX Common Stock C - Conversion I 78.298 78.298
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund I, QP, LP. CGTX Common Stock C - Conversion I 245.029 245.029
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP By Bios Fund I, LP. CGTX Common Stock C - Conversion I 418.926 418.926
2021-10-15 2021-10-13 4 BIOS Memory SPV I, LP CGTX Common Stock C - Conversion D 1.424.014 1.424.014
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Warrant (right to buy) X - Other D 0,03 -27.471 0
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Series B-1 Convertible Preferred Stock C - Conversion D -438.854 0
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Series B Convertible Preferred Stock C - Conversion D -4.087.046 0
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Series A-2 Convertible Preferred Stock C - Conversion D -882.233 0
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Series A-1 Convertible Preferred Stock C - Conversion D -333.333 0
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Series A Convertible Preferred Stock C - Conversion D -1.319.408 0
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock S - Sale D 12,0000 -74 -1 2.210.377
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock X - Other D 0,0320 27.471 1 2.210.452
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock C - Conversion D 135.679 2.182.981
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock C - Conversion D 1.263.575 2.047.302
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock C - Conversion D 272.756 783.727
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock C - Conversion D 103.055 510.971
2021-10-15 2021-10-13 4 Ogden CAP Associates, LLC CGTX Common Stock C - Conversion D 407.916 407.916
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Series A-1 Convertible Preferred Stock C - Conversion D -884.058 0
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Simple Agreement for Future Equity C - Conversion D 0
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Warrant (right to buy) X - Other D 0,03 -12.276 0
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Series B-1 Convertible Preferred Stock C - Conversion D -1.574.370 0
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Series B Convertible Preferred Stock C - Conversion D -4.004.181 0
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Series A-2 Convertible Preferred Stock C - Conversion D -542.496 0
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock C - Conversion D 311.706 2.489.691
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock S - Sale D 12,0000 -33 -0 2.177.985
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock X - Other D 0,0320 12.276 0 2.178.019
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock C - Conversion D 486.742 2.165.743
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock C - Conversion D 1.237.959 1.679.001
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock C - Conversion D 167.721 441.042
2021-10-15 2021-10-13 4 Golden Seeds Cognition Therapeutics LLC CGTX Common Stock C - Conversion D 273.321 273.321
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, NT, LP. CGTX Simple Agreement for Future Equity C - Conversion I -25.593 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, QP, LP. CGTX Simple Agreement for Future Equity C - Conversion I -158.476 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, LP. CGTX Simple Agreement for Future Equity C - Conversion I -24.263 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Memory SPV II, LP. CGTX Warrant (right to buy) X - Other I 0,03 -33.495 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, NT, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -111.504 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, QP, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -1.930.673 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -134.626 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, NT, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -110.744 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Memory SPV II, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -1.138.040 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, QP, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -827.275 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, LP. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -253.256 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund I, QP, LP. CGTX Series B Convertible Preferred Stock C - Conversion I -792.547 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund I, LP. CGTX Series B Convertible Preferred Stock C - Conversion I -1.355.017 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. CGTX Series B Convertible Preferred Stock C - Conversion D -4.605.985 0
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, NT, LP. CGTX Common Stock C - Conversion I 25.593 60.065
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, NT, LP. CGTX Common Stock C - Conversion I 34.472 34.472
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, QP, LP. CGTX Common Stock P - Purchase I 12,0000 144.530 1.734 899.905
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, QP, LP. CGTX Common Stock C - Conversion I 158.476 755.375
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, QP, LP. CGTX Common Stock C - Conversion I 596.899 596.899
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, LP. CGTX Common Stock P - Purchase I 12,0000 22.129 266 88.012
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, LP. CGTX Common Stock C - Conversion I 24.263 65.883
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund III, LP. CGTX Common Stock C - Conversion I 41.620 41.620
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Memory SPV II, LP. CGTX Common Stock S - Sale I 12,0000 -90 -1 385.248
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Memory SPV II, LP. CGTX Common Stock X - Other I 0,0320 33.495 1 385.339
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Memory SPV II, LP. CGTX Common Stock C - Conversion I 351.844 351.844
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, NT, LP. CGTX Common Stock P - Purchase I 12,0000 23.341 280 57.579
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, NT, LP. CGTX Common Stock C - Conversion I 34.238 34.238
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, QP, LP. CGTX Common Stock C - Conversion I 255.765 255.765
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund II, LP. CGTX Common Stock C - Conversion I 78.298 78.298
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund I, QP, LP. CGTX Common Stock C - Conversion I 245.029 245.029
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Fund I, LP. CGTX Common Stock C - Conversion I 418.926 418.926
2021-10-15 2021-10-13 4 Fletcher Aaron G.L. By Bios Memory SPV I, LP. CGTX Common Stock C - Conversion I 1.424.014 1.424.014
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Warrant (Right to Buy) X - Other I 0,03 -4.354 0
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Series B-1 Convertible Preferred Stock C - Conversion I -301.978 0
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Series B Convertible Preferred Stock C - Conversion I -826.278 0
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Series A-2 Convertible Preferred Stock C - Conversion I -118.835 0
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Series A-1 Convertible Preferred Stock C - Conversion I -144.928 0
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Common Stock S - Sale I 12,0000 -12 -0 404.439
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Common Stock C - Conversion I 0,0320 4.354 0 404.451
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Common Stock C - Conversion I 93.296 400.097
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Common Stock C - Conversion I 225.281 306.801
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Common Stock C - Conversion I 36.714 81.520
2021-10-15 2021-10-13 4 Breedlove Mark H. By Breedlove Family Limited Partnership. CGTX Common Stock C - Conversion I 44.806 44.806
2021-10-14 2021-10-13 4 Ricciardi Lisa CGTX Common Stock P - Purchase D 12,0000 12.500 150 12.500
2021-10-14 2021-10-13 4 O'Brien James Michael CGTX Common Stock P - Purchase D 12,0000 5.000 60 5.000
2021-10-12 2021-10-07 4 Ricciardi Lisa CGTX Stock Option (right to buy) A - Award D 12,00 290.509 290.509
2021-10-12 2021-10-07 4 Ricciardi Lisa CGTX Stock Option (right to buy) A - Award D 12,00 290.509 290.509
2021-10-12 2021-10-07 4 Ricciardi Lisa CGTX Stock Option (right to buy) A - Award D 12,00 547.965 547.965
2021-10-12 2021-10-07 4 O'Brien James Michael CGTX Stock Option (right to buy) A - Award D 12,00 54.457 54.457
2021-10-07 3 Breedlove Mark H. CGTX Common Stock D 7.611
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista